Search
for
Sort by
Research 781–810 of 1000+
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Plants as potential active components in treatment of androgenetic alopecia
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- Preparation, Characterization and Molecular Docking Study of some New Pyrazole Derivatives Derived from 2-Mercaptobenzothiazole.
- Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption
- The hair growth promoting effect of Sophora flavescens extract and its molecular regulation
- Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- Pathogenesis of androgenetic alopecia
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Regulation of masculinization: androgen signalling for external genitalia development
- Anabolic effects of testosterone are preserved during inhibition of 5α-reductase
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Hair loss
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Pumpkin Seed Oil-Loaded Niosomes for Topical Application: 5α-Reductase Inhibitory, Anti-Inflammatory, and In Vivo Anti-Hair Loss Effects
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- The role of androgens in hormone replacement therapy
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia